The global precision oncology market is projected to grow from USD 120.9 billion in 2024 to USD 310.75 billion by 2034, representing a robust compound annual growth rate (CAGR) of 9.9% over the period from 2024 to 2034.
CONSIGNEE NAME | SHIPPER NAME | PRODUCT DESCRIPTION | QUANTITY | WEIGHT |
STRIDES PHARMA INC | STRIDES PHARMA GLOBAL PTELIMITED | PHARMACEUTICAL PRODUCTS | 1577 | 10544 |
NORTHSTAR DISTRIBUTION CENTER 8912 | AVET LIFESCIENCES PRIVATE LIMITED | PHARMA HTS: 300490 | 17 | 5715 |
BOEKEL SCIENTIFIC | FOUR E S SCIENTIFIC HONGKONG LIMITED | LAB-JACKS | 218 | 3932 |
HOSPIRA WORLDWIDE INC | PFIZER HEALTHCARE INDIA PRIVATE LIMITED | PHARMACEUTICALS LIDOCAINE HCL | 34 | 12931 |
UPS SUPPLY CHAIN SOLUTIONS | LUPIN LIMITED | DULOXETINE DR CAP 30MG 30S USP 1013 CARTONS | 40 | 12823 |